Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01126567 · ClinicalTrials.gov registry record
Exploratory Biomarker Study of Cerebrospinal Fluid in Healthy Volunteers
A clinical trial of Healthy, sponsored by Abbott.
- Completed
- Registry status
- 8
- Enrollment target
- 1
- Study location
NCT01126567: Completed study of Healthy, sponsored by Abbott.
NCT01126567 is a study of Healthy that has completed, run by Abbott. The registered enrollment target is 8 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01126567, a study of Healthy, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to determine the effects of cerebrospinal fluid sampling rate on biomarker levels of young, healthy volunteers.
Conditions Studied
Interventions
- OTHER Sampling Rate
Study Locations (1)
California
- - Glendale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2009-12 |
| Est. Completion | 2010-02 |
What the finished NCT01126567 record still lists
NCT01126567 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Sampling Rate is the first listed.
NCT01126567 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01126567 about?
NCT01126567 is a clinical study titled "Exploratory Biomarker Study of Cerebrospinal Fluid in Healthy Volunteers". The objective of this study is to determine the effects of cerebrospinal fluid sampling rate on biomarker levels of young, healthy volunteers.
What is the current status of trial NCT01126567?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2009-12. Estimated completion is 2010-02.
What conditions does trial NCT01126567 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT01126567?
The interventions under investigation include: Sampling Rate (OTHER).
Who is sponsoring clinical trial NCT01126567?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01126567 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01126567's enrollment target sits among peer trials
8 1061st of 1090 higher than 18 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia